KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
688298 Zhejiang Orient Gene Biotech
- 31.24
- -0.86-2.68%
Market Closed Dec 13 15:00 CST
6.30BMarket Cap-10.72P/E (TTM)
32.04High31.19Low26.95KlotVolume32.03Open32.10Pre Close84.59MTurnover1.34%Turnover RatioLossP/E (Static)201.60MShares41.4952wk High0.92P/B6.30BFloat Cap24.4052wk Low38.52Limit Up201.60MShs Float239.66Historical High25.68Limit Down2.65%Amplitude24.40Historical Low--Dividend TTM31.39Avg Price17.58KlotAsk--Div YieldTTM100Lot Size8.65KlotBid
Zhejiang Orient Gene Biotech Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 0.83%657.61M | -16.61%418.24M | -51.36%182.92M | -90.65%820.16M | -91.70%652.17M | -92.95%501.54M | -92.08%376.05M | -13.78%8.77B | 6.18%7.86B | 11.43%7.11B |
| Operating revenue | 0.83%657.61M | -16.61%418.24M | -51.36%182.92M | -90.65%820.16M | -91.70%652.17M | -92.95%501.54M | -92.08%376.05M | -13.78%8.77B | 6.18%7.86B | 11.43%7.11B |
| Total operating cost | 41.33%1.02B | 36.41%624.19M | -32.46%286.55M | -80.22%1B | -82.14%718.72M | -87.39%457.57M | -80.84%424.27M | 16.05%5.07B | 47.66%4.02B | 61.22%3.63B |
| Operating cost | 4.75%429.48M | -16.80%269.3M | -51.08%123.75M | -89.17%467.4M | -88.26%409.99M | -89.31%323.66M | -85.37%252.96M | 61.87%4.31B | 105.33%3.49B | 121.17%3.03B |
| Operating tax surcharges | -9.18%5.13M | -13.10%3.09M | -59.81%1.17M | -83.17%15.07M | -92.40%5.64M | -92.55%3.55M | -88.01%2.92M | 23.09%89.55M | 73.84%74.25M | 71.36%47.68M |
| Operating expense | -1.22%115.65M | -4.94%72.5M | -13.63%34.73M | -66.57%162.19M | -75.34%117.08M | -82.48%76.26M | -86.87%40.21M | -53.30%485.11M | -31.03%474.82M | -27.33%435.31M |
| Administration expense | 20.62%301.54M | 29.73%204.64M | 16.59%90.02M | 37.56%372.36M | 27.29%249.99M | 21.22%157.74M | 117.11%77.21M | 186.43%270.69M | 241.72%196.4M | 237.67%130.12M |
| Financial expense | 81.79%-45.92M | 68.49%-71.64M | -3,645.95%-35.09M | 54.32%-275.58M | 59.00%-252.11M | 36.69%-227.39M | -106.85%-936.84K | -997.21%-603.27M | -7,663.48%-614.94M | -1,820.36%-359.18M |
| -Interest expense (Financial expense) | 22.22%14.33M | 69.45%10.26M | 22.55%3.5M | 160.09%18.12M | 59.11%11.73M | 222.28%6.05M | 1,249.43%2.86M | 644.10%6.97M | 1,544.22%7.37M | 706.22%1.88M |
| -Interest Income (Financial expense) | 47.10%-83.74M | 29.15%-71.65M | -0.77%-43.05M | -77.73%-207.67M | -90.15%-158.3M | -152.46%-101.12M | -246.11%-42.72M | -235.09%-116.84M | -249.17%-83.25M | -142.36%-40.05M |
| Research and development | 11.56%209.88M | 18.23%146.3M | 38.65%71.96M | -49.01%260.86M | -52.99%188.14M | -64.40%123.74M | -50.61%51.9M | 19.38%511.56M | 64.69%400.24M | 77.64%347.61M |
| Credit Impairment Loss | -1.44%419.63K | -2,780.04%-6.48M | -317.99%-4.69M | -573.14%-27.53M | -98.72%425.77K | 94.60%-224.96K | 94.96%-1.12M | 117.53%5.82M | 588.28%33.32M | 96.55%-4.16M |
| Asset Impairment Loss | -3.54%-16.64M | 0.40%-9.02M | -108.64%-3.25M | 80.45%-236.51M | 90.91%-16.07M | 95.11%-9.06M | --37.63M | -7,156.37%-1.21B | -140.90%-176.89M | -666.17%-185.39M |
| Other net revenue | ||||||||||
| Fair value change income | 1,730.91%15.16M | 1,763.22%15.46M | 3,127.97%28.15M | -641.47%-8.99M | -5,822.38%-929.53K | -5,822.38%-929.53K | -6.35%-929.53K | 3,705.97%1.66M | ---15.7K | ---15.7K |
| Invest income | 132.89%70.76M | 98.60%42.5M | 43.84%15.28M | 597.51%42.01M | 455.66%30.38M | 310.41%21.4M | 2,081.57%10.62M | -45.97%6.02M | -238.11%-8.54M | -373.35%-10.17M |
| -Including: Investment income associates | -82.09%-2.39M | -235.75%-1.54M | -357.76%-861.11K | -178.28%-1.5M | ---1.31M | ---459.23K | ---188.11K | --1.91M | ---- | ---- |
| Asset deal income | 655.10%904.17K | -158.53%-55.15K | -95.53%6.36K | -2,150.74%-178.97K | -215.87%-162.88K | 24,739.67%94.23K | --142.31K | -169.21%-7.95K | 818.87%140.57K | -97.53%379.36 |
| Other revenue | -40.98%5M | -31.23%3.76M | 53.58%680.7K | 20.13%29.5M | -35.15%8.47M | -44.73%5.47M | -50.19%443.22K | 87.59%24.56M | 409.54%13.05M | 99.25%9.9M |
| Operating profit | -535.82%-282.55M | -363.10%-159.78M | -4,565.92%-67.45M | -115.18%-383.83M | -101.20%-44.44M | -98.16%60.73M | -100.06%-1.45M | -56.23%2.53B | -19.95%3.7B | -17.57%3.29B |
| Add:Non operating Income | 61.70%6.89M | -12.92%3.67M | -97.56%16.2K | 1,219.25%4.21M | 1,342.05%4.26M | 2,073.16%4.21M | -9.12%664.97K | 250.15%319.2K | 399.03%295.37K | 53,835,430.56%193.81K |
| Less:Non operating expense | -66.54%2.03M | -76.72%1.33M | -98.16%678.7K | -57.42%24.6M | -85.66%6.06M | -76.18%5.73M | 90.96%36.87M | 785.54%57.78M | 617.29%42.28M | 379.98%24.04M |
| Total profit | -500.53%-277.69M | -365.89%-157.45M | -80.90%-68.12M | -116.36%-404.23M | -101.27%-46.24M | -98.19%59.22M | -101.51%-37.66M | -57.18%2.47B | -20.76%3.65B | -18.06%3.27B |
| Less:Income tax cost | -116.45%-3.46M | -87.80%2.59M | -79.01%1.84M | -96.24%14.04M | -96.29%21.03M | -95.69%21.27M | -97.77%8.76M | -54.98%373.32M | -17.34%566.94M | -16.47%493.08M |
| Net profit | -307.67%-274.23M | -521.76%-160.04M | -50.72%-69.96M | -119.94%-418.27M | -102.18%-67.27M | -98.63%37.95M | -102.21%-46.41M | -57.55%2.1B | -21.35%3.09B | -18.34%2.78B |
| Net profit from continuing operation | -307.67%-274.23M | -521.76%-160.04M | -50.72%-69.96M | -119.94%-418.27M | -102.18%-67.27M | -98.63%37.95M | -102.21%-46.41M | -57.55%2.1B | -21.35%3.09B | -18.34%2.78B |
| Net income from discontinuing operating | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Less:Minority Profit | -335.88%-12.07M | -368.79%-8.44M | -166.42%-2.6M | -169.61%-20.69M | -85.31%5.12M | -90.99%3.14M | -87.75%3.92M | 45.26%29.72M | 584.32%34.83M | 499.97%34.85M |
| Net profit of parent company owners | -262.17%-262.16M | -535.56%-151.61M | -33.82%-67.35M | -119.23%-397.58M | -102.37%-72.38M | -98.73%34.81M | -102.44%-50.33M | -57.97%2.07B | -22.14%3.05B | -19.23%2.74B |
| Earning per share | ||||||||||
| Basic earning per share | -266.67%-1.32 | -547.06%-0.76 | -10.00%-0.33 | -116.00%-1.97 | -101.98%-0.36 | -98.96%0.17 | -101.74%-0.3 | -69.98%12.31 | -44.40%18.16 | -42.31%16.32 |
| Diluted earning per share | -266.67%-1.32 | -547.06%-0.76 | -10.00%-0.33 | -116.00%-1.97 | -101.98%-0.36 | -98.96%0.17 | -101.74%-0.3 | -69.98%12.31 | -44.40%18.16 | -42.31%16.32 |
| Other composite income | -170.56%-17.55M | -91.12%2.57M | 37.01%-8.35M | -65.58%14.11M | -64.03%24.88M | 9.20%28.92M | -772.73%-13.26M | 926.50%40.99M | 5,943.94%69.17M | 1,454.64%26.48M |
| Other composite income of parent company owners | -170.56%-17.55M | -91.12%2.57M | 37.01%-8.35M | -65.58%14.11M | -64.03%24.88M | 9.20%28.92M | -772.73%-13.26M | 926.50%40.99M | 5,943.94%69.17M | 1,454.64%26.48M |
| Total composite income | -588.35%-291.78M | -335.51%-157.48M | -31.23%-78.31M | -118.90%-404.16M | -101.34%-42.39M | -97.61%66.87M | -102.85%-59.67M | -56.67%2.14B | -19.61%3.16B | -17.51%2.8B |
| Total composite income of parent company owners | -488.79%-279.71M | -333.87%-149.04M | -19.05%-75.71M | -118.19%-383.48M | -101.52%-47.51M | -97.70%63.73M | -103.08%-63.59M | -57.10%2.11B | -20.40%3.12B | -18.40%2.77B |
| Total composite income of minority owners | -335.88%-12.07M | -368.79%-8.44M | -166.42%-2.6M | -169.61%-20.69M | -85.31%5.12M | -90.99%3.14M | -87.75%3.92M | 45.26%29.72M | 584.32%34.83M | 499.97%34.85M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
